Latest Breaking News On - Previously stated - Page 7 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. BioNTech Announces First Quarter 2021 Financial Results and Corporate Update BioNTech SEMay 10, 2021 GMT More than 450 million doses of BNT162b2 supplied to 91 countries or territories worldwide as of May 6, 2021 Signed agreements for over 1.8 billion doses of BNT162b2 in 2021 and first contracts signed for periods 2022 and beyond Announced planned expansion of global footprint to Asia with establishment of first regional headquarters for south east Asia in Singapore, including a fully-integrated and state-of-the art mRNA manufacturing facility In oncology, a first-in-human Phase 1 trial started for the neoantigen-targeting T cell therapy, BNT221. The development of BioNTech’s oncology pipeline has continued to accelerate with 14 product candidates now in 15 ongoing trials

United statesUnited kingdomSouth africaSylke maasSanofi libtayoUgur sahinFosun pharmaAutogene cevumeranUs centers for diseaseSingaporean economic development boardAssociation for cancer immunotherapyEuropean commissionDrug administrationInternational olympic committeeBayer animal healthDevelopment expenses